299 related articles for article (PubMed ID: 29341581)
21. Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy.
Lai C; Lin S; Liu W; Jin Y
Curr Med Chem; 2024; 31(21):3074-3092. PubMed ID: 37062062
[TBL] [Abstract][Full Text] [Related]
22. Advances in preparation and characterization of chitosan nanoparticles for therapeutics.
Chandra Hembram K; Prabha S; Chandra R; Ahmed B; Nimesh S
Artif Cells Nanomed Biotechnol; 2016; 44(1):305-14. PubMed ID: 25137489
[TBL] [Abstract][Full Text] [Related]
23. Biomedical and Pharmacological Uses of Fluorescein Isothiocyanate Chitosan-Based Nanocarriers.
Caprifico AE; Polycarpou E; Foot PJS; Calabrese G
Macromol Biosci; 2021 Jan; 21(1):e2000312. PubMed ID: 33016007
[TBL] [Abstract][Full Text] [Related]
24. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
[TBL] [Abstract][Full Text] [Related]
25. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
[TBL] [Abstract][Full Text] [Related]
26. Biopolymeric alginate-chitosan nanoparticles as drug delivery carriers for cancer therapy.
Bhunchu S; Rojsitthisak P
Pharmazie; 2014 Aug; 69(8):563-70. PubMed ID: 25158565
[TBL] [Abstract][Full Text] [Related]
27. Cancer cell-specific photoactivity of pheophorbide a-glycol chitosan nanoparticles for photodynamic therapy in tumor-bearing mice.
Oh IH; Min HS; Li L; Tran TH; Lee YK; Kwon IC; Choi K; Kim K; Huh KM
Biomaterials; 2013 Sep; 34(27):6454-63. PubMed ID: 23755832
[TBL] [Abstract][Full Text] [Related]
28. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
Kamath PR; Sunil D
Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
[TBL] [Abstract][Full Text] [Related]
29. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications.
Sung HW; Sonaje K; Liao ZX; Hsu LW; Chuang EY
Acc Chem Res; 2012 Apr; 45(4):619-29. PubMed ID: 22236133
[TBL] [Abstract][Full Text] [Related]
30. Effect of polymer molecular weight on the tumor targeting characteristics of self-assembled glycol chitosan nanoparticles.
Park K; Kim JH; Nam YS; Lee S; Nam HY; Kim K; Park JH; Kim IS; Choi K; Kim SY; Kwon IC
J Control Release; 2007 Oct; 122(3):305-14. PubMed ID: 17643545
[TBL] [Abstract][Full Text] [Related]
31. pH-sensitive and specific ligand-conjugated chitosan nanogels for efficient drug delivery.
Xing L; Fan YT; Shen LJ; Yang CX; Liu XY; Ma YN; Qi LY; Cho KH; Cho CS; Jiang HL
Int J Biol Macromol; 2019 Dec; 141():85-97. PubMed ID: 31473314
[TBL] [Abstract][Full Text] [Related]
32. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery.
Parveen S; Sahoo SK
Eur J Pharmacol; 2011 Nov; 670(2-3):372-83. PubMed ID: 21951969
[TBL] [Abstract][Full Text] [Related]
33. Self-assembled glycol chitosan nanoparticles for the sustained and prolonged delivery of antiangiogenic small peptide drugs in cancer therapy.
Kim JH; Kim YS; Park K; Kang E; Lee S; Nam HY; Kim K; Park JH; Chi DY; Park RW; Kim IS; Choi K; Chan Kwon I
Biomaterials; 2008 Apr; 29(12):1920-30. PubMed ID: 18289669
[TBL] [Abstract][Full Text] [Related]
34. Chitosan Nanoparticles-Insight into Properties, Functionalization and Applications in Drug Delivery and Theranostics.
Jhaveri J; Raichura Z; Khan T; Momin M; Omri A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33430478
[TBL] [Abstract][Full Text] [Related]
35. Recent advances of chitosan nanoparticles as drug carriers.
Wang JJ; Zeng ZW; Xiao RZ; Xie T; Zhou GL; Zhan XR; Wang SL
Int J Nanomedicine; 2011; 6():765-74. PubMed ID: 21589644
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
Cheng M; Ma D; Zhi K; Liu B; Zhu W
Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
[TBL] [Abstract][Full Text] [Related]
37. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
[TBL] [Abstract][Full Text] [Related]
38. Glycol Chitosan: A Water-Soluble Polymer for Cell Imaging and Drug Delivery.
Lin F; Jia HR; Wu FG
Molecules; 2019 Nov; 24(23):. PubMed ID: 31795385
[TBL] [Abstract][Full Text] [Related]
39. Review on marine carbohydrate-based gold nanoparticles represented by alginate and chitosan for biomedical application.
Chen X; Zhao X; Wang G
Carbohydr Polym; 2020 Sep; 244():116311. PubMed ID: 32536396
[TBL] [Abstract][Full Text] [Related]
40. Positively Charged Nanostructured Lipid Carriers and Their Effect on the Dissolution of Poorly Soluble Drugs.
Choi KO; Choe J; Suh S; Ko S
Molecules; 2016 May; 21(5):. PubMed ID: 27213324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
